Cardio Diagnostics Stock Quote CDIO - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.08

Bid

1.08

Ask

1.10

Volume

229,163

0.00 Day's Range 0.00

0.19 52 Week Range 3.56

Market Cap

43.675M

Previous Close

1.08

Open

Last Trade

131

1.08

(formt)

Last Trade Time

07:44:31

Financial Volume

VWAP

Average Volume (3m)

5,653,170

Shares Outstanding

40,439,810

Dividend Yield

PE Ratio

-5.21

Earnings Per Share (EPS)

-0.21

Revenue

17k

Net Profit

-8.38M

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Headquarters

Dover, Delaware, USA

Founded

Cardio Diagnostics Holdings Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was $1.08. Over the last year, Cardio Diagnostics shares have traded in a share price range of $ 0.19 to $ 3.56.

Cardio Diagnostics currently has 40,439,810 shares outstanding. The market capitalization of Cardio Diagnostics is $43.67 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -5.21.

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, today announced it will sponsor and exhibit at the Florida Association of ACOs (FLAACOs...

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Preliminary CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision...

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its redesigned website at CDIO.AI. This new site...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at...

Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company will sponsor a booth and showcase its groundbreaking...

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-driven precision cardiovascular medicine, today announced the successful completion of its System and Organization Controls (SOC...

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

Company to recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the Molecular Diagnostic Services (MolDx) program. Cardio Diagnostics Holdings, Inc. (NASDAQ:...

Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood tests, Epi+Gen CHD and PrecisionCHD...

Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually

The Peer-Reviewed Publication Demonstrates the Potential Economic Benefits of the PrecisionCHD™ Test for the Detection and Management of Coronary Heart Disease, which is One of the Largest Cost...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.78	260	0.3	1.19	0.277	29913978	0.61111306	CS
4	0.74	217.647058824	0.34	1.19	0.2153	8942329	0.55792744	CS
12	0.8	285.714285714	0.28	1.19	0.19	5653170	0.43398951	CS
26	0.4781	79.4317993022	0.6019	1.19	0.19	2799443	0.43427228	CS
52	-0.29	-21.1678832117	1.37	3.56	0.19	1925541	0.85871735	CS
156	-3.17	-74.5882352941	4.25	8.4999	0.171	3027499	1.68384022	CS
260	-3.17	-74.5882352941	4.25	8.4999	0.171	3027499	1.68384022	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CADLCandel Therapeutics Inc	$ 11.70 (153.80%)	8.4M
NIVFNewGenIvf Group Ltd	$ 0.747 (91.05%)	13.35M
LAESSEALSQ Corporation	$ 1.06 (85.64%)	42.82M
PDCOPatterson Companies Inc	$ 31.05 (34.36%)	47.57k
NLSPNLS Pharmaceutics Ltd	$ 2.61 (31.82%)	601.27k
QTTBQ32 Bio Inc	$ 8.44 (-65.42%)	70.25k
CLRBCellectar Biosciences Inc	$ 0.562 (-56.09%)	1.08M
TFFPTFF Pharmaceuticals Inc	$ 0.1905 (-36.98%)	150.06k
FBYDFalcons Beyond Global Inc	$ 8.51 (-26.06%)	2.85k
AMLIAmerican Lithium Corporation	$ 0.4679 (-25.16%)	199.32k
LAESSEALSQ Corporation	$ 1.06 (85.64%)	42.82M
RZLVRezolve AI Ltd	$ 2.35 (21.76%)	14.6M
NIVFNewGenIvf Group Ltd	$ 0.747 (91.05%)	13.35M
RGTIRigetti Computing Inc	$ 7.27 (12.02%)	11.8M
SMXSMX Security Matters Public Company	$ 0.3701 (6.23%)	10.58M